Sunday November 22 2009 | Biotechnology feed | All feeds

«UCB Pharma

Below is an extended UCB Pharma patents listing. Click here to return to the UCB Pharma main Biocorporate entry.

UCB Pharma Patents :
US Patent No.	Title
7608694	Antibody molecules having specificity for human IL-1.beta.
7456286	Bicyclic heteroaromatic compounds as kinase inhibitors
7452976	Biological products
7419659	Expression control using variable intergenic sequences
7402662	Antibody molecules specific to human tumor necrosis factor alpha
7355011	Biological products
7300765	SC6 for diagnosis of cancers
7297760	Cancer associated protein
7273744	Heparanase-like polypeptides
7479283	Acellular pertussis vaccine comprising a combination of the 69 kDa and the filamentous haemagglutinin antigens of Bordetella pertussis
7488741	4-Aminopiperidine derivatives, processes for their preparation and their use as medicaments
7601817	Antibody peg positional isomers, compositions comprising same, and use thereof
7592455	Bicyclic heteroaromatic compounds as kinase inhibitors
7563912	Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of Levetiracetam and analogues
7557130	Bicyclic heteroaromatic alanines
7531549	Phenylalanine enamide derivatives
7521460	Thienopyridone derivatives as kinase inhibitors
7504353	Hydrogenation catalysts
7501437	Phenylalanine enamide derivatives
7169399	Non-toxic double mutant forms of pertussis toxin as adjuvants

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.